201 related articles for article (PubMed ID: 30799084)
21. Aquaporin 9 inhibits hepatocellular carcinoma through up-regulating FOXO1 expression.
Li CF; Zhang WG; Liu M; Qiu LW; Chen XF; Lv L; Mei ZC
Oncotarget; 2016 Jul; 7(28):44161-44170. PubMed ID: 27329843
[TBL] [Abstract][Full Text] [Related]
22. Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro.
Mirdamadi Y; Thielitz A; Wiede A; Goihl A; Papakonstantinou E; Hartig R; Zouboulis CC; Reinhold D; Simeoni L; Bommhardt U; Quist S; Gollnick H
Mol Cell Endocrinol; 2015 Nov; 415():32-44. PubMed ID: 26257240
[TBL] [Abstract][Full Text] [Related]
23. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
Lian R; Lu B; Jiao L; Li S; Wang H; Miao W; Yu W
Eur J Pharmacol; 2016 Dec; 792():1-6. PubMed ID: 27751825
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
25. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway.
Huang Y; Fan X; Tao R; Song Q; Wang L; Zhang H; Kong H; Huang J
J Cell Physiol; 2018 Oct; 233(10):6693-6704. PubMed ID: 29323718
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
[TBL] [Abstract][Full Text] [Related]
27. HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway.
Theofilatos D; Fotakis P; Valanti E; Sanoudou D; Zannis V; Kardassis D
Metabolism; 2018 Oct; 87():36-47. PubMed ID: 29928895
[TBL] [Abstract][Full Text] [Related]
28. miRNA-223 suppresses FOXO1 and functions as a potential tumor marker in breast cancer.
Wei YT; Guo DW; Hou XZ; Jiang DQ
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):113-118. PubMed ID: 28719355
[TBL] [Abstract][Full Text] [Related]
29. Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation in vitro.
Baek JM; Ahn SJ; Cheon YH; Lee MS; Oh J; Kim JY
Mol Med Rep; 2017 Feb; 15(2):784-792. PubMed ID: 28035412
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling.
Liu H; Liu N; Zhao Y; Zhu X; Wang C; Liu Q; Gao C; Zhao X; Li J
Aging (Albany NY); 2019 Nov; 11(21):9643-9660. PubMed ID: 31689236
[TBL] [Abstract][Full Text] [Related]
31. SIRT1-mediated FoxO1 deacetylation is essential for multidrug resistance-associated protein 2 expression in tamoxifen-resistant breast cancer cells.
Choi HK; Cho KB; Phuong NT; Han CY; Han HK; Hien TT; Choi HS; Kang KW
Mol Pharm; 2013 Jul; 10(7):2517-27. PubMed ID: 23763570
[TBL] [Abstract][Full Text] [Related]
32. The regulation of FOXO1 and its role in disease progression.
Xing YQ; Li A; Yang Y; Li XX; Zhang LN; Guo HC
Life Sci; 2018 Jan; 193():124-131. PubMed ID: 29158051
[TBL] [Abstract][Full Text] [Related]
33. MiR-613 Promotes Cell Death in Breast Cancer Cells by Downregulation of Nicotinamide Phosphoribosyltransferase and Reduction of NAD.
Alizadeh-Fanalou S; Hosseinkhani S; Nazarizadeh A; Ezzati-Mobaser S; Hesari Z; Aziminezhadan P; Abdolvahabi Z; Abolmaali M; Tavakoli-Yaraki M; Nourbakhsh M
DNA Cell Biol; 2021 Jul; 40(7):1026-1036. PubMed ID: 34101492
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells.
Zhang H; Ge Z; Tang S; Meng R; Bi Y; Zhu D
Mol Med Rep; 2017 Aug; 16(2):2295-2301. PubMed ID: 28656239
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
[TBL] [Abstract][Full Text] [Related]
36. Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Wang L; Zhang B; Zheng W; Kang M; Chen Q; Qin W; Li C; Zhang Y; Shao Y; Wu Y
Sci Rep; 2017 Jul; 7(1):5384. PubMed ID: 28710412
[TBL] [Abstract][Full Text] [Related]
37. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.
Shi H; Fang R; Li Y; Li L; Zhang W; Wang H; Chen F; Zhang S; Zhang X; Ye L
Cancer Lett; 2016 Nov; 382(2):147-156. PubMed ID: 27609066
[TBL] [Abstract][Full Text] [Related]
38. B cell receptor signaling down-regulates forkhead box transcription factor class O 1 mRNA expression via phosphatidylinositol 3-kinase and Bruton's tyrosine kinase.
Hinman RM; Bushanam JN; Nichols WA; Satterthwaite AB
J Immunol; 2007 Jan; 178(2):740-7. PubMed ID: 17202334
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
Xu H; Zhu J; Hu C; Song H; Li Y
J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
[TBL] [Abstract][Full Text] [Related]
40. Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 pathway.
Guo LT; Wang SQ; Su J; Xu LX; Ji ZY; Zhang RY; Zhao QW; Ma ZQ; Deng XY; Ma SP
J Neuroinflammation; 2019 May; 16(1):95. PubMed ID: 31068207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
